Skip to content

Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection Using Wharton’s Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans®): open Phase IB Clinical Trial

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519391-11-00
Acronym
Protrans V
Enrollment
9
Registered
2024-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection, Respiratory viral disease

Interventions

None listed

Sponsors

NextCell Pharma AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026